Clinical Trials

40 enrolled

Hypertension, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT07582159 2026-05-12

Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

35 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07557056 2026-04-29

Nemtabrutinib and Venetoclax for the Treatment of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

25 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07463976 2026-04-13

TITLE CLL

130 enrolled

Phase 1/2 Not yet recruiting

Leukemia, Lymphocytic, Chronic, B-Cell, Hematologic Neoplasms

NCT07520006 2026-04-13

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

150 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT07526597 2026-04-13

STOP-CLL-DCT

45 enrolled

Phase 3 Not yet recruiting

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07516093 2026-04-08

Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

620 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT07508995 2026-04-03

A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL)

40 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06971848 2026-03-30

ETCABIO

GastrointestinalLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellThoracic

70 enrolled

Immunoglobulin Light-chain Amyloidosis, Esophageal Squamous Cell Carcinoma, Mesothelioma, Malignant, Carcinoma, Bronchogenic, Heart Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Follicular, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Cholangiocarcinoma, Neoplasms, Plasma Cell

NCT07476378 2026-03-17

Archonc-001

69 enrolled

Phase 4 Not yet recruiting

Lymphoma, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT07426484 2026-02-23

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

DermatologicLymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Waldenstrom Macroglobulinemia, Skin Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasms, Plasma Cell

NCT07412405 2026-02-17

ACITAC-001

12 enrolled

Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT07024706 2026-01-21

MAVRiC

Phase 3 Not yet recruiting

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07321652 2026-01-07

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

466 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07286539 2025-12-16

PEPOH

BreastGastrointestinalLymphoidOther hematologic neoplasmThoracic

150 enrolled

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Lymphoma, Motor Activity, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Hematologic Neoplasms

NCT07225439 2025-11-06

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

Phase 1 Not yet recruiting

15 enrolled

Phase 1/2 Not yet recruiting

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT06979076 2025-09-29

A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL

12 enrolled

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT07162532 2025-09-09

Clinico-hematological and Molecular Characteristics of Chronic Lymphocytic Leukemia Patients

45 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07157579 2025-09-05

Notch 1 Mutation in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patient

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07113132 2025-08-08

Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia

84 enrolled

Phase 3 Not yet recruiting

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07082452 2025-07-24

SEVENAZA

262 enrolled

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute

NCT06862323 2025-06-13

Time Restricted Eating in Haematological Malignancies

75 enrolled

Intermittent Fasting, Inflammation, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

NCT07003464 2025-06-04

Phase II Trial of Zanubrutinib, Obinutuzumab, Bendamustine (ZGB) as First-Line Therapy for Chronic Lymphocytic Leukemia: A Single-Center Study

30 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06654206 2025-02-19

Effects of a Strength Physical Exercise Program in Chronic Lymphocytic Leukemia Patients

40 enrolled

Motor Activity, Leukemia, Lymphocytic, Chronic, B-Cell

NCT05371392 2024-06-20

Polymorphism of ITGA4 Gene in Chronic Lymphocytic Leukemia

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06416267 2024-05-16

MBL RiskConseq

1,500 enrolled

Alzheimer Disease, Autoimmune Diseases, Cardiovascular Diseases, Dementia, Infections, Neoplasms, Parkinson Disease, Leukemia, Lymphocytic, Chronic, B-Cell

NCT06364033 2024-05-09

Biological and Clinical Efficacy of Shingrix in Patients With CLL

312 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05718986 2024-05-08

Familial_LPD

LymphoidOther hematologic neoplasmOther neoplasm

1,000 enrolled

Lymphoproliferative Disorders, Precancerous Conditions, Leukemia, Lymphocytic, Chronic, B-Cell

NCT06367374 2024-04-16

MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLL

66 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06084923 2024-04-10

Outcomes of Unfit Patients With CLL Included in the GIMEMA LLC1114 Trial Who Discontinued Ibrutinib Due to Reasons Other Than Disease Progression

73 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05923502 2023-10-23

(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)

200 enrolled

Phase 4 Not yet recruiting

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, B-Cell, Marginal Zone

NCT04790045 2023-10-03

LymBIO

30 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05899543 2023-06-12

Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients

500 enrolled